Unlike [11C]Martinostat, which provides good brain penetration and targets HDAC enzymes, [11C]GSK023’s limited brain uptake may restrict its applications in central nervous system disorders but proves beneficial for studying peripheral disease states where BET proteins are implicated, such as in certain cancers or inflammatory diseases. This evidence concerns the gene HDAC9 and central nervous system disorder.